URL has been copied successfully!

URL has been copied successfully!

JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT

On: April 19, 2026

URL has been copied successfully!

Please follow us:

This post was originally published here

Previous Post:National Bank Downgrades Newmont (NEM) to “Sector Perform” Amid Rising Costs Tied to Higher Diesel Prices

Next Post:Truist Cuts PT on Amcor plc (AMCR) to $50 Amid Higher Energy and Freight Costs